Senior insider sale
Sr VP, Drug Discovery at ADAPTIVE BIOTECHNOLOGIES CORP — senior position signals high conviction
$260.6K
12.87K shares
What this filing means
BENZENO SHARON plans to sell 12.87K shares of ADAPTIVE BIOTECHNOLOGIES CORP valued at approximately $260.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/26/2026ACC: 0001950047-26-006564
Officer· Sr VP, Drug Discovery
Since Jun 2019
12.87K
Shares to sell
$260.6K
Approx. market value
12.87K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
6/26/2026
12.87KTotal acquired12.87K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/26/2026 | Exercise of Stock Options Cash | 12.87K | — |
| Total | 12.87K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
12.87K
Market value
$260.6K
6/26/2026
Total
Units
12.87K
Value
$260.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/26/2026 | 12.87K | $260.6K | NASDAQ | Planned |
| Total | 12.87K | $260.6K | ||